News
-
-
-
PRESS RELEASE
Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, further expanding industry-leading pipeline
Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, expanding industry-leading pipeline. Agreement includes cetuximab, evolocumab, belimumab biosimilars, and option for human hyaluronidase -
-
-
-
-
-
-